JPS6153334B2 - - Google Patents
Info
- Publication number
- JPS6153334B2 JPS6153334B2 JP56146338A JP14633881A JPS6153334B2 JP S6153334 B2 JPS6153334 B2 JP S6153334B2 JP 56146338 A JP56146338 A JP 56146338A JP 14633881 A JP14633881 A JP 14633881A JP S6153334 B2 JPS6153334 B2 JP S6153334B2
- Authority
- JP
- Japan
- Prior art keywords
- bark
- hot water
- extract
- extraction
- water extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 55
- 239000000284 extract Substances 0.000 claims description 52
- 201000011510 cancer Diseases 0.000 claims description 21
- 235000002568 Capsicum frutescens Nutrition 0.000 claims description 6
- 238000000862 absorption spectrum Methods 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 5
- 230000009876 antimalignant effect Effects 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 4
- 230000001613 neoplastic effect Effects 0.000 claims 3
- 238000000605 extraction Methods 0.000 description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 29
- 206010028980 Neoplasm Diseases 0.000 description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 206010003445 Ascites Diseases 0.000 description 11
- 208000006268 Sarcoma 180 Diseases 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 238000000502 dialysis Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000002054 transplantation Methods 0.000 description 6
- 241000349731 Afzelia bipindensis Species 0.000 description 5
- 229940034982 antineoplastic agent Drugs 0.000 description 5
- 239000002246 antineoplastic agent Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 241000208365 Celastraceae Species 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 235000000336 Solanum dulcamara Nutrition 0.000 description 4
- 241000999879 Themelium Species 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000003495 polar organic solvent Substances 0.000 description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 230000000118 anti-neoplastic effect Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 238000005534 hematocrit Methods 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000227585 Alstonia constricta Species 0.000 description 2
- 241001131796 Botaurus stellaris Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 208000032839 leukemia Diseases 0.000 description 2
- 235000009973 maize Nutrition 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 210000003200 peritoneal cavity Anatomy 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 239000012264 purified product Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- -1 sorbitan fatty acid ester Chemical class 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56146338A JPS5849317A (ja) | 1981-09-18 | 1981-09-18 | 抗悪性新生物剤 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56146338A JPS5849317A (ja) | 1981-09-18 | 1981-09-18 | 抗悪性新生物剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5849317A JPS5849317A (ja) | 1983-03-23 |
JPS6153334B2 true JPS6153334B2 (de) | 1986-11-17 |
Family
ID=15405429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56146338A Granted JPS5849317A (ja) | 1981-09-18 | 1981-09-18 | 抗悪性新生物剤 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5849317A (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61232149A (ja) * | 1985-03-29 | 1986-10-16 | 北海製罐株式会社 | 飲料缶の溶接缶胴 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004256426A (ja) * | 2003-02-25 | 2004-09-16 | Kuniaki Nejime | 抗腫瘍剤 |
-
1981
- 1981-09-18 JP JP56146338A patent/JPS5849317A/ja active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61232149A (ja) * | 1985-03-29 | 1986-10-16 | 北海製罐株式会社 | 飲料缶の溶接缶胴 |
Also Published As
Publication number | Publication date |
---|---|
JPS5849317A (ja) | 1983-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS60214741A (ja) | 血糖降下剤 | |
US4536496A (en) | Polysaccharides N9GI, their preparation and therapeutic compositions containing them | |
JPS6153334B2 (de) | ||
JPH0643330B2 (ja) | 麦類青汁系血糖降下剤 | |
JPS6153335B2 (de) | ||
US4501736A (en) | Extract from barrenwort | |
JPS6152808B2 (de) | ||
US3151108A (en) | Kryptoescin and process of making same | |
JP4480204B2 (ja) | カワリハラタケの抗腫瘍性画分 | |
JPH02286620A (ja) | 抗高脂血症用剤 | |
JPS6213931B2 (de) | ||
JPS6153332B2 (de) | ||
JPS6153333B2 (de) | ||
JPS6152809B2 (de) | ||
JPS63267726A (ja) | 抗腫瘍剤 | |
JP2519443B2 (ja) | 複合多糖類、該複合多糖類を有効成分とする血糖降下剤、糖尿病予防薬及び健康食品 | |
JPS59184129A (ja) | 多糖体t25g1およびその製造法 | |
JPH0120132B2 (de) | ||
JPS6153336B2 (de) | ||
JPS6025931A (ja) | 制癌剤 | |
JPS6216428A (ja) | ヒメヒオウギズイセンから得られる生物活性物質及びその製法 | |
KR840001510B1 (ko) | 삼지구엽초 sp속 식물로부터의 추출물 제조방법 | |
CN118108870A (zh) | 一种石斛多糖衍生物的制备方法及在抗肿瘤药物中的应用 | |
JPS6318961B2 (de) | ||
JPH0469633B2 (de) |